Skip to main content
. 2022 May 16;36(5):645–652. doi: 10.1177/02698811221093796

Table 1.

Demographic and physical characteristics.

HC
(n = 67)
Asymptomatic BD
(n = 48)
Symptomatic BD
(n = 39)
F/H/ χ2 p-value Effect size
Age 17.06 ± 1.38 17.51 ± 1.60 17.43 ± 1.64 1.42 0.25 0.02
Sex (n, % female) 39 (58%) 31 (65%) 27 (69%) 1.36 0.51 0.09
Race (n, %) c European 36 (54%) 37 (77%) 29 (74.5%) 27.59 0.02* 0.30
South East/Eastern Asian 12 (18%) 1 (2%) 2 (5.1%)
Black or African 7 (10.5%) 1 (2%) 0 (0%)
South Asian 5 (7.5%) 0 (0%) 1 (2.6%)
Hispanic 2 (3%) 2 (4%) 2 (5.1%)
Aboriginal 0 (0%) 0 (0%) 1 (2.6%)
West Asian or Middle Eastern 0 (0%) 1 (2%) 1 (2.6%)
Other 5 (7%) 6 (13%) 3 (7.5%)
Intact family (n, % yes) 45 (67%) 32 (67%) 25 (64%) 0.11 0.95 0.03
BMI (adjusted)a,b 22.20 ± 3.69 23.28 ± 3.57 25.66 ± 5.60 14.34 0.001* 0.08
Blood pressure diastolic 68.16 ± 7.69 69.49 ± 7.35 70.29 ± 9.10 0.95 0.39 0.01
Blood pressure systolic 107.60 ± 12.30 108.63 ± 12.60 110.55 ± 13.34 0.67 0.51 0.01
Tanner Stage d 5 20 (30%) 25 (53%) 26 (70%) 20.33 0.002* 0.26
4 41 (62%) 19 (41%) 9 (24%)
3 5 (8%) 3 (6%) 1 (3%)
2 0 (0%) 0 (0%) 1 (3%)
CRP (mg/L) ⩾ 1 (n, %) e 13 (19%) 20 (42%) 17 (46%) 9.27 0.01* 0.25
CRP (mg/L) ⩾ 3 (n, %) e 4 (6%) 9 (19%) 9 (23%) 7.03 0.03* 0.21
CRP (mg/L) ⩾ 5 (n, %) f 1 (1%) 2 (4%) 5 (13%) 6.57 0.04* 0.21

BD: bipolar disorder; HC: healthy control; BMI: body mass index. CRP: high-sensitivity C-reactive protein.

Non-normally distributed, examined using nonparametric Kruskal–Wallis test.

Results are reported as mean ± standard deviation (SD) unless otherwise specified.

Effect size was reported as partial eta square =  ηp2 for ANOVA, eta square = η2 for Kruskal–Wallis, and Cramér’s V = V for Crosstab

Missing cases (n): blood pressure diastolic (2); blood pressure systolic (1); Tanner stage (4).

a

Symptomatic showed higher value compared with HC.

b

Asymptomatic showed higher value compared with HC.

c

HC showed higher percentage of South East/Eastern Asian ancestry than the other two groups.

d

Symptomatic showed lower percentage of stage 4 and higher percentage of stage 5 compared with HC.

e

HC showed lower percentage compared with the other two groups.

f

Symptomatic group showed higher percentage than the other two groups.

*

Significant difference.